Sonder Capital Closes Second Fund Futures II to Transform Patient Care
Bruker Appoints Laura Francis to its Board of Directors
J&J beats quarterly sales and profit estimates on cancer drug sales By Reuters
J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal By Reuters
Healthcare executives expect more IPOs and corporate dealmaking in 2025 By Reuters
Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。
